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Vascular endothelial growth factor B (VEGF-B) is a potent mediator of vascular, metabolic,
growth, and stress responses in the heart, but the effects on cardiac muscle and
cardiomyocyte function are not known. The purpose of this study was to assess
the effects of VEGF-B on the energy metabolism, contractile, and electrophysiological
properties of mouse cardiac muscle and cardiac muscle cells. In vivo and ex vivo analysis
of cardiac-specific VEGF-B TG mice indicated that the contractile function of the TG
hearts was normal. Neither the oxidative metabolism of isolated TG cardiomyocytes
nor their energy substrate preference showed any difference to WT cardiomyocytes.
Similarly, myocyte Ca2+ signaling showed only minor changes compared to WT
myocytes. However, VEGF-B overexpression induced a distinct electrophysiological
phenotype characterized by ECG changes such as an increase in QRSp time and
decreases in S and R amplitudes. At the level of isolated TG cardiomyocytes, these
changes were accompanied with decreased action potential upstroke velocity and
increased duration (APD60–70). These changes were partly caused by downregulation
of sodium current (INa) due to reduced expression of Nav1.5. Furthermore, TG myocytes
had alterations in voltage-gated K+ currents, namely decreased density of transient
outward current (Ito) and total K
+ current (Ipeak). At the level of transcription, these
were accompanied by downregulation of Kv channel-interacting protein 2 (Kcnip2), a
knownmodulatory subunit for Kv4.2/3 channel. Cardiac VEGF-B overexpression induces
a distinct electrophysiological phenotype including remodeling of cardiomyocyte ion
currents, which in turn induce changes in action potential waveform and ECG.
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INTRODUCTION
The Vascular Endothelial Growth Factor (VEGF) family consists of five proteins with regulative
roles in blood and lymphatic vessel growth and development (Bry et al., 2014). The angiogenic
potency of VEGFs makes them attractive candidates for therapy of ischemic heart (Vuorio et al.,
2012). However, among the VEGFs, the effects of VEGF-B spread beyond vessel regulation as
it has been implicated in the regulation of myocardial metabolism, growth, and stress-response
(Karpanen et al., 2008; Huusko et al., 2012; Kivela et al., 2014). VEGF-B is expressed in a variety
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of tissues with highest expression in heart and oxidative skeletal
muscle (Hagberg et al., 2010). Alternative splicing of the VEGF-
B gene produces two isoforms, VEGF-B167 and VEGF-B186,
which both mediate their effects by binding to VEGFR-1
(Olofsson et al., 1998) and NRP-1 receptors (Makinen et al.,
1999). When overexpressed, VEGF-B activates Akt/mTORC1
and ERK1/2 MAPK pathways (Kivela et al., 2014). Data from
genetic rodent models suggest that VEGF-B is not a prerequisite
for cardiac development or function, but rather serves as a
regulatory factor. Supporting this, VEGF-B deficient mice are
viable and show only mild cardiac phenotype with either
atrial conduction defect (Aase et al., 2001) or retarded growth
accompanied with slightly impaired coronary vasculature and
reduced ischemic tolerance ex vivo (Bellomo et al., 2000).
Similarly, VEGF-B deficient rats have no obvious abnormalities
in either contractile or vascular function (Kivela et al., 2014).
Transgenic overexpression of VEGF-B inmouse (Karpanen et al.,
2008) or rat heart (Bry et al., 2010; Kivela et al., 2014) induces
metabolic remodeling, moderate hypertrophy, and myocardial
capillary enlargement with improved ischemic tolerance. VEGF-
B delivery into myocardium with adenoviruses in rodent or
pig hearts consistently produces an increase in the density
or diameter of the myocardial capillaries, and AAV-VEGF-B
delivery appears to protect the heart against ischemia-, pacing-,
or load-induced cardiomyopathy (Bry et al., 2014). So far, studies
on cardiac effects of VEGF-B have been mainly conducted in the
context of angiogenic therapy to enhance perfusion of the heart
and metabolic effects on the myocardium. However, the effects
of VEGF-B on myocardial function at the level of cardiac muscle
cells are not known. The purpose of this study was to assess the
effects of VEGF-B on the energy metabolism, contractile, and
electrophysiological properties of the mouse heart.
MATERIALS AND METHODS
Experimental Animals
The present studies employed 2–4 months old transgenic
(TG) mice overexpressing human VEGF-B167 and VEGF-B186
isoforms (Supplementary Figure S1) under the cardiac-specific
myosin heavy chain promoter (Bry et al., 2010). VEGF-B TG
mice were bred into the C57Bl/6JOlaHsd background for over 10
generations. TG-negative littermates (WT) were used as controls
in all experiments. The animals were kept in standard housing
conditions in The National Laboratory Animal Center of The
University of Eastern Finland. Diet and water were provided ad
libitum. All animal experiments were performed according the
guidelines of Directive 2010/63/EU of the European Parliament
on the protection of animals used for scientific purposes, the
procedures were also approved by the Animal Experiment Board
in Finland and carried out in accordance with the guidelines of
the Experimental Animal Committee of the University of Eastern
Finland.
Echocardiography and
Electrocardiography
Ten TG and ten WT littermate controls were used for
echocardiographic and electrocardiographic measurements
performed with the Vevo2100 Ultrasound System (VisualSonics
Inc., Toronto, ON, Canada). A high-frequency ultrasound probe
(MS400) operating at 30MHz with a minimum of 300 frames per
second was used. The animals were anesthetized with isoflurane
(induction: 4.5% isoflurane, 450mL air, maintenance: 2.0%
isoflurane, 200mL air, Baxter International Inc., Deerfield, IL,
USA). Mice were placed in a supine position on a heated platform
(THM100, Indus Instruments, Houston, TX, USA) to maintain
the body temperature at 36–37◦C. Ejection fraction (EF), left
ventricle anterior wall thickness (LVAW), left ventricle volume
(LV Vol), and left ventricle mass (LV Mass) were determined
from parasternal short axis M-Mode measurements. EF was
calculated by Vevo2100 software using the Teicholz formula.
To obtain the ECG signal, the paws of the mice were connected
to the electrode pads on the platform using ECG gel and fixed
with a skin tape. The recorded ECG represents the standard limb
lead II. The mouse heart rate and respiration were monitored
during anesthesia via ECG pads. The raw data of ECG were
analyzed with a Matlab-based ECG analysis program (Kubios
HRV, version 2.0 beta 4, Department of Physics, University of
Eastern Finland, Kuopio, Finland), which was modified specially
for analyzing mouse ECG (Merentie et al., 2015). Time intervals
(QRS, QRSp, and QTc time) and amplitudes of R and S wave
were analyzed from the mean curve generated from a 30-s ECG
recording. QTc time was calculated as QT ms/(R− R0/100 ms)
1/2
(Mitchell et al., 1998).
Langendorff Heart Perfusion Model
For ex vivo heart studies, conventional Langendorff perfusion
was used (Bell et al., 2011). Isolated hearts were perfused with
37◦C Krebs-Henzeleit buffer solution and paced by surface
electrodes at 8 Hz in all experiments. To record left ventricular
pressure (LVP), a water-filled PVC balloon was inserted into the
left ventricle (LV). Heart rate and LVP were monitored with an
HSE ISOTECH Pressure Transducer and recorded with a data
acquisition board (PCI-6052E, National Instruments, Austin,
TX, USA). Collected data were analyzed with WinEDR software
(University of Strathclyde, Glasgow, UK). To assess the substrate
specificity (glucose vs. palmitate) of the isolated hearts, the
buffer solution was supplemented with 1.2 mM sodium palmitate
(Sigma-Aldrich, St. Louis, MO, USA) conjugated to fatty acid-
free bovine serum albumin (BSA, Sigma-Aldrich, St. Louis,
MO, USA) (Belke et al., 1999) or with 11 mM glucose and
unconjugated BSA.
Single Cell Isolation
Adult mouse ventricular myocytes were obtained by enzymatic
dissociation as described before (AfCS Procedure Protocol
PP00000125). Briefly, isolated hearts were placed in a
Langendorff apparatus for perfusion (37◦C, 3 mL/min)
with a trypsin (Sigma) and liberase (Roche Applied Science)
solution. After that, ventricles were cut into small pieces and
gently minced with a Pasteur pipette. The concentration of Ca2+
in solution was increased slowly up to 1 mM. The suspension of
cells was placed on laminin-coated coverslips and stored in an
incubator (5% CO2 at 37
◦C).
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Size Measurement of the Isolated
Cardiomyocytes
Adult cardiomyocyte size was assessed with a Coulter Counter
Z2 (Beckman Coulter) equipped with a 200µmaperture and data
analyzedwith Accucomp software (BeckmanCoulter). 20% of the
isolated cells from one heart were suspended in 2 mL medium
and 10 mL Beckman Isoton II diluent (Beckman Coulter) was
added. The metered volume was 1 mL, main gain 32 and
aperture current 0.250. From each analysis mean and median
cell volumes of the cell population above the size of 20,000 fL
were recorded. The cell population below 20,000 fL (equal to a
spherical particle with 17µm diameter) was contaminated with
smaller cells and cell debris, and therefore discarded from the
analysis (Supplementary Figure S2).
Western Blot
Frozen ventricular tissue was lysed with a TissueLyser II (Qiagen)
and protein concentration of the lysate was measured with
the Bio-Rad Protein Assay. Ten to fifty micrograms of protein
was loaded onto an 8–12% SDS polyacrylamide gel. After gel
electrophoresis, proteins were transferred to a nitrocellulose
membrane (0.2µm, Bio-Rad Laboratories), which was blocked
with 5% BSA. For blotting of the large (240 kDa) Nav1.5
protein, a gradient gel (4–15%, Bio-Rad Laboratories, #456–
1,083) was used and protein samples transferred to a 0.4µm
membrane. Membranes were incubated with primary antibody,
after which incubation with Cy5 (GE Healthcare, PA45012) or
Cy3 (PA43010)-linked secondary antibody was performed and
blots visualized with the ECL Plus Detection Kit (GE Healthcare)
using a Typhoon 9400 scanner (GE Healthcare). The antibodies
used were: Anti-Nav1.5 (Alomone labs, ASC-005), Anti-VEGF-B
(R&D Systems, Af751), and β-actin (Cell Signaling Technology,
4967). Ponceau S staining solution (Sigma-Aldrich, St. Louis,
MO, USA) was used as per manufacturer’s instructions to
visualize total membrane protein as a loading control for the
blotted Nav1.5 protein.
Metabolic Analysis of Isolated
Cardiomyocytes
To assess mitochondrial respiration, a Seahorse XF24 Analyzer
(Seahorse Bioscience, North Billerica, MA, USA) was used as
described in the Online Data Supplement. To assess the substrate
specificity (glucose vs. palmitate) of the isolated cardiomyocytes,
the assay buffer was supplemented with 200µM sodium
palmitate (Sigma-Aldrich, St. Louis, MO, USA) conjugated to
fatty acid-free bovine serum albumin (BSA, Sigma-Aldrich,
St. Louis, MO, USA; Belke et al., 1999) or with 25mM glucose
and unconjugated BSA.
Gene Expression
Primers and probes designed to detect mouse mRNA transcripts
in Taqman-based RT-qPCR are listed in Supplementary Table S1.
Patch-Clamp Experiments
For individual currents or action potential measurements, an
Axopatch-200B amplifier and Digidata 1440A A/D-D/A and
Clampex 10 software (Axon Instruments, Sunnyvale, CA, USA)
were used as previously (Karppinen et al., 2016). Previously
described solutions and protocols were used for L-type Ca2+
current (Xu et al., 2011), K+ currents (Rivard et al., 2009),
Na+-currents (Sato et al., 2009; Sossalla et al., 2010), and for
action potential measurements (Yang et al., 2005). Late INa was
estimated as integration of the current from 50 to 250 ms
of the beginning of the depolarizing pulse (250ms) without
and with ranolazine (10µM) in the bath solution. Current-
voltage relations for steady-state activation and inactivation for
calcium and sodium currents were determined by fitting a
Boltzmann function (I/Imax = [1 + exp ((V − V1/2)/k)]
−1),
yielding the membrane potential of the half-maximal activation
(V1/2-activation) and inactivation (V1/2-inactivation) and slope
factor (k). The current recovery from inactivation curves were
fitted using a single exponential function. Data analysis was made
using Clampfit10 software (Molecular Devices Inc., USA).
FIGURE 1 | In vivo cardiac function, cell size, and gene expression of
hypertrophy markers in VEGF-B mice. (A) In vivo echocardiography data of left
ventricle (LV): ejection fraction (LV EF%, upper left), diastolic anterior wall
thickness (LVAW;d, upper right), diastolic volume (LV Vol;d, lower left), and
mass (LV Mass, lower right, n = 10 for both groups). (B) Size of the isolated
cardiomyocytes. Left panel: representative Coulter Counter histograms. Middle
panel: average of means and medians from populations of cells isolated from
hearts (WT; six hearts, 4152 ± 1770 cells/analysis TG; seven hearts, 6,040 ±
1,533 cells/analysis). Right panel: means of cell capacitances measured in
whole-cell experiments (WT n = 8/51 and TG n = 10/58; animals/cells).
(C) Gene markers of cardiac hypertrophy [mRNA to WT ratio: natriuretic
peptide A (Nppa), natriuretic peptide B (Nppb), skeletal actin (Acta1), myosin
heavy polypeptide 6 (Myh6), and myosin heavy polypeptide 7 (Myh7); WT
n = 7 and TG n = 6]. *P < 0.05, #P < 0.001.
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Ca2+ Measurements
Adult cardiomyocytes were loaded with Fluo-4-acetoxymethyl
(AM)-ester (10µM; 0.02% pluronic acid, Invitrogen, Carlsbad,
CA, USA), calcium signals were recorded with a confocal
microscope, and data were analyzed as previously (Tavi et al.,
2005; Korhonen et al., 2010).
Computer Modeling
Some of the in vitro experiments were replicated in silico
to evaluate the contribution of individual VEGF-B related
changes on AP morphology, using mathematical model of
mouse ventricular myocyte (Koivumaki et al., 2009). The VEGF-
B related modifications were implemented to mutant model
FIGURE 2 | Cell energy metabolism and ex vivo cardiac function.
(A) Extracellular acidification and oxygen consumption in isolated
cardiomyocytes supplemented with either glucose (Gluc) or palmitate (Palm).
Top panels: representative plots of extracellular acidification rate (ECAR, left)
and oxygen consumption rate (OCR, right). Bottom panels: basal and
FCCP-induced maximal ECAR (left) and OCR [right, n = 35 wells with ∼2,000
cells each, from seven (7 WT and 7 TG mice) independent paired assays]. (B)
Ex vivo systolic heart function in glucose- (Gluc) and palmitate-based (Palm)
solutions. Systolic pressure (LVP, upper left), diastolic pressure (Diast.press.,
upper right), systole rise slope (dP/dT, lower left), and systole decay slope
(−dP/dT, lower right, n = 6 in both groups). (C) Ventricular expression of the
genes (normalized to WT) related to energy metabolism: fatty acid transporter
(Slc27a1), glucose transporter (Slc2a4), carnitine palmitoyltransferase 1B
(Cpt1b), mitochondrial transcription factor A (Tfam), muscle
phosphofructokinase (Pfkm), and peroxisome proliferator-activated receptor
gamma coactivator 1-alpha (Ppargc1a) (WT n = 7 and TG n = 6) *P < 0.05.
variants based on experimental data, details are available in the
Supplementary Methods.
Statistical Testing
Data and statistical analyses were made using Origin9 software
(OriginLab Corp., Northampton, MA, USA). For statistical
analysis, one-way ANOVAwith Fisher’s post-hoc comparison was
performed for all ion currents and calcium transient frequency
dependence, as well as Student’s t-tests where appropriate, were
applied at a level of significance of P < 0.05. Data are given as
mean values± SEM.
RESULTS
VEGF-B Mice Display Normal Heart
Function and Cardiomyocyte Hypertrophy
without Metabolic Changes
VEGF-B has been shown to induce multiple adaptations in the
heart, including angiogenesis and muscle growth (Bry et al.,
FIGURE 3 | Ca2+ handling in VEGF-B TG ventricular myocytes.
(A) Representative [Ca2+]i transients (line-scans) and their profiles in
Fluo4-loaded cardiomyocytes upon pacing at different stimulus frequencies in
WT and TG mice (upper), frequency dependence of amplitudes (lower left),
and time constants (lower right) of the [Ca2+]i transients (n = 16 myocytes for
WT and n = 22 myocytes for TG, at least three animals were used for both
groups). (B) Representative line-scans and profiles of stimulus- and
caffeine-induced [Ca2+]i pulses in WT (upper left) and TG mice (upper right).
Amplitudes (lower left) and time constant of decays (lower middle) of stimulus-
(Stim) and caffeine-induced (Caff) transients, and fractional release (lower right,
WT n = 23 myocytes and TG n = 26 myocytes, at least three animals were
used for both groups). *P < 0.05, ¤P < 0.01 and #P < 0.001.
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2014). According to echocardiographic analysis, the VEGF-
B mice had normal systolic and diastolic heart function and
mild signs of cardiac hypertrophy (Figure 1). However, there
was a significant increase in the volume and cell capacitance
of isolated VEGF-B cardiomyocytes (Figure 1B, Supplementary
Figure S2). This was accompanied with increased expression
of the hypertrophy markers Nppb and Acta1 (Figure 1C),
indicating an induction of hypertrophic pathways. Cardiac
VEGF-B overexpression in rats has been shown to induce
metabolic changes with decreased expression of fatty acid
oxidation genes and increased concentration of intermediates of
glucose metabolism (Kivela et al., 2014). We therefore assessed
the oxidative and anaerobic metabolism and substrate preference
of isolated cardiomyocytes with a Seahorse extracellular flux
analyser. Extracellular acidification (ECAR), which reflects
glycolysis rate, did not differ between the TG and WT
cardiomyocytes and neither was there a difference in oxygen
consumption (OCR) between the groups (Figure 2A). Moreover,
we did not find changes in the energy substrate preferences;
basal and maximal ECAR and OCR were similar in WT and TG
animals when the energy source was either glucose or fatty acid
(palmitate, Figure 2A). To assess the effect of energy substrate on
the contractile function of the heart, we fed Langendorff-perfused
hearts either glucose or palmitate and measured LV function. We
saw no difference between TG and WT LV function with either
glucose or palmitate (Figure 2B). In line with these findings,
expression of genes related to cellular and mitochondrial energy
metabolism was similar in TG and WT hearts (Figure 2C).
Collectively, our data suggest that in isolated TG cardiomyocytes,
changes in energy metabolism are not evident. Furthermore, the
VEGF-B induced metabolic changes do not involve changes in
substrate uptake, as suggested earlier (Kivela et al., 2014).
VEGF-B Overexpression Augments Ca2+
Signals in Ventricular Myocytes
Next, we studied if VEGF-B overexpression affects the [Ca2+]i
signaling of the myocytes. To challenge the cells, we first
stimulated Fluo-4-loaded isolated cardiomyocytes at different
frequencies (0.5–10Hz, Figure 3A). The amplitude of [Ca2+]i
transients was higher in TG cardiomyocytes at low stimulus
frequencies (0.5–2Hz, Figure 3A). The time constant of [Ca2+]i
transient decay, which indicates calcium extrusion rate, was
shorter but only at the lowest pacing frequency (0.5Hz,
Figure 3A). SR Ca2+ loading, estimated by rapid application
of caffeine (10mM; Figure 3B) was higher in TG myocytes
(Figure 3B). While VEGF-B TG myocytes showed increased
[Ca2+]i transient amplitude and SR-load, the fractional release,
assessed by the ratio of stimulus- and caffeine-induced [Ca2+]i
transients, was not altered in TG vs. WT myocytes. These
changes were accompanied with downregulation of Atp2a2
(Serca2a) expression, whileAtp2a2/phospholamban ratio was not
altered (Supplementary Figure S3B). Moreover, caffeine induced
[Ca2+]i transient was shorter in TG animals (Figure 3B) which
could reflect increased INCX. Taken together, although VEGF-
B TG myocytes show augmented calcium transients (CaTs)
and increased SR load, these changes are not due to extensive
remodeling and are likely to have a relatively small impact on
cardiomyocyte function at physiological heart rates in vivo.
FIGURE 4 | Electrophysiological properties of VEGF-B TG hearts and isolated cardiomyocytes. (A) Representative ECG recordings from WT (black line) and VEGF-B
TG (red line) mice. (B) Enlarged superimposed ECG complexes (left panel) with summary of the ECG parameters (right panel, n = 10 for both groups).
(C) Representative superimposed AP traces from isolated myocytes (left) and means of the AP maximum rise slope (upper right) and rise time (lower right). (D) AP
durations at different percentages of repolarization (WT n = 17 and TG n = 34; 4 animals for both group). *P < 0.05, ¤P < 0.01 and #P < 0.001.
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VEGF-B Induces Alterations of
Electrophysiological Properties of the
Mouse Heart
VEGF-B deficiency has been shown to interfere with atrial
conduction in mice (Aase et al., 2001), indicating that
VEGF-B regulates mechanisms maintaining electrophysiological
properties of the heart. Thus, VEGF-B overexpression might
result in remodeling of electrical properties of myocardium.
Comparison of the ECGs of WT and VEGF-B TG mice
indicated drastic changes in the ECG waveform of TG hearts
(Figures 4A,B). Specifically, TG hearts had decreased amplitudes
of R- and S-waves accompanied by an increase in the QRSp
time which reveals early repolarization in the heart (Figure 4B),
whereas QRS width was not changed. ECG changes, such as
those seen in VEGF-B TG hearts, can be induced by changes
in the electrical properties of myocytes or passive properties of
the heart tissue (Dhein et al., 2014). VEGF-B TG hearts had
no signs of fibrosis based on LV relaxation (Figure 2B) and
histology (data not shown) or changes in the expression patterns
of connexin isoforms (Supplementary Figure S3A), but isolated
ventricular myocytes had significant changes in action potential
(AP) waveform. However, TG myocytes had no significant
changes in APD90 they had increased duration of AP at 60 and
70% of repolarization (∼40 and ∼45% in APD60 and APD70,
respectively; Figures 4C,D). Furthermore, TG myocytes had an
increase in the rise time and slowing ofmaximum rise slope of the
AP upstroke (Figure 4C). These results suggest that ECG changes
are due to remodeling of the electrical properties of the myocytes
involving both depolarizing and repolarizing currents.
VEGF-B TG Myocytes Have Depressed INa
To specify the ion current changes causing ECG and AP
changes in VEGF-B TG hearts, we first measured L-type Ca2+
channel current (ICaL) from cardiomyocytes isolated from TG
and WT hearts. We saw no differences in the I–V-dependence,
density, activation/inactivation, or expression of the Cacna1c
gene encoding the pore-forming subunit of the L-type channel
(Figure 5A, Supplementary Table S2). In contrast to ICaL
the other major depolarizing current, INa was significantly
decreased in VEGF-B TG myocytes (Figure 5B). The decrease
of the INa density was accompanied with downregulation of
the Scn5a mRNA and Nav1.5 protein (Figure 5C). Moreover,
INa from VEGF-B TG myocytes showed a rightward shift in
both voltage-dependent activation and inactivation (Figure 5D,
Supplementary Table S3) without a change in recovery time
after inactivation (Figure 5D, Supplementary Table S3). Another
property of Na-channels subject to modifications is the slowly
inactivating component (Gintant et al., 1984), also known as
the late Na-current. Since the late INa has been linked to ECG
changes such as those seen in VEGF-B mice (Moreno and
Clancy, 2012), we assessed the INa-L in VEGF-B TG myocytes.
However, we did not find differences in late INa between WT
and TG myocytes either with INa-L blocker ranolazine or by
a voltage clamp protocol specific for late Na+-current even in
condition when physiological [Na+]out concentration was used
(Supplementary Figure S4). Altogether, decreased INa gives a
FIGURE 5 | Depolarizing currents in VEGF-B TG myocytes. (A) I–V curves of
ICaL densities (left panel, WT n = 9 and TG n = 11, myocytes from three
animals in both groups), voltage-dependent activation/inactivation of ICaL
(middle panel, Boltzmann fitting) and gene expression of α-subunit calcium
channel (Cacna1c, right panel). (B) Typical sodium channel current traces (left
panel) and I–V curves (right panel) (WT black line, n = 19 and TG red line
n = 14 myocytes from 3 mice were used for both groups). (C) Gene
expression of sodium channel subunits Scn5a and Scn4b (left, WT n = 7 and
TG n = 6) and Western blot of Nav1.5 from membrane protein fraction.
Nav1.5 western blot signal normalized to Ponceau stain (middle, WT n = 3,
TG n = 4). Representative SCN5a bands and Ponceau stain from the same
region of the membrane (right). (D) Voltage-dependent activation and
inactivation of sodium channels (left panel) and recovery time from inactivation
(right panel) (see Table S3 for fitting results, WT n = 19 myocytes and TG n =
15 myocytes from three animals in both groups). Refer to insets for
voltage-step protocols. *P < 0.05, ¤P < 0.01 and #P < 0.001.
reasonable explanation for the ECG anomalies (Figures 4A,B)
and decrease in the AP upstroke velocity (Figure 4C).
VEGF-B Affects the Expression and
Density of Potassium Currents
In general, the AP repolarization is determined by the potassium
currents, of which transient outward and delayed rectifier
currents are the most prominent ones in mouse ventricular
myocytes (Nerbonne, 2004). While there was relatively small
change in the total K+ current (∼18%; Figure 6A), VEGF-B
overexpression shown drastic decreasing of transient outward
current (Ito, Figure 6B). Moreover, decreasing of Ito in VEGF-
B animals was accompanied with significant acceleration of
inactivation of this current (by ∼1.7-fold). The ultra-rapid
component of delayed rectifier current as well as IK1 and IKss
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were unaffected (IKur, IK1, and IKss Figures 6C,D). Channels
responsible for fast and slow Ito are assembled by α-subunits
Kv4.2 and Kv1.4, encoded by genes Kcna4 and Kcnd2,
respectively (Nerbonne, 2004). However, expression of these
genes was not different between WT and TG myocytes; instead,
we saw downregulation of Kcnip2 Kv channel-interacting protein
2 (ß-subunit), a known modulatory subunit of the Kv4.2/3
channel (Figure 6E). This indicates that VEGF-B regulates AP
repolarization partly by affecting the expression of potassium
channel subunits and accessory proteins.
Effects of VEGF-B-Related Alterations on
Electrophysiology
To elucidate the isolated contribution of VEGF-B-related
modifications of INa, Ito, and INCX on electrophysiology
(Figures 5, 6), we replicated the AP experiments (Figure 4)
in silico, together with the effect of EGTA Ca2+ buffer used
in experiments (Figure 7A), using a computational model of
mouse ventricular myocyte (Koivumaki et al., 2009). Model
simulations recapitulated well the emergent changes in the
AP morphology (Figure 7B). As the comparison of simulated
APs shows (Figure 7B), the sodium and potassium channel
modifications partially cancel out each other, and thus the
sum effect on repolarization is smaller in the virtual VEGF-B
myocyte. The reduced INa (Figure 7C) lead to a 12.0% decrease
in maximum upstroke velocity of the AP. The indirect effect of
slower AP repolarization is that the inactivation of IKss, ICaL, and
IKur is decelerated (Figure 7D).
Furthermore, we studied the possible interdependence of
AP changes and the apparent changes in CaT amplitude with
simulations of more physiological conditions (without EGTA;
Figure 7E). While the enhanced NCX activity (Figure 7G)
should result in increased Ca2+ extrusion and thus reduced CaT
amplitude, the simulations demonstrate that due the reduced
Ito the initial repolarization phase is much slower (Figure 7F),
which decelerates the inactivation of ICaL (Figure 7H) and thus
increases the integral of Ca2+ influx by +39%. As a result, the
CaT amplitude is increased by 24% (Figure 7E).
DISCUSSION
Here, we studied the effect of VEGF-B overexpression in
mouse heart at the level of cardiac myocytes. We report
that cardiac-specific overexpression of VEGF-B induces mild
changes in cardiomyocyte calcium signaling and growth
without pathological metabolic remodeling. Interestingly, our
results show that VEGF-B induces marked changes in the
electrophysiological properties of cardiomyocytes, including
changes in densities of both depolarizing and repolarizing
currents, ECG, and action potential parameters.
Particular changes in mouse ECG complex correlate with
certain cardiac conditions such as aging, infarction, and LV
hypertrophy (LVH) (Merentie et al., 2015); these changes can
be used to estimate disease progression (Sysa-Shah et al., 2015).
VEGF-B TG hearts show two distinct ECG changes. First
is increase in the width of the QRSp which together with
FIGURE 6 | Voltage-gated potassium currents. Representative superimposed original traces (upper, obtained at + 50mV) and I–V curves (lower) of (A) total
potassium (Ipeak ), (B) transient outward (Ito), and (C) ultra-rapid (IKur) currents. (D) I–V curves of K1 and steady state currents (IK1/IKss, WT black and TG red lines,
WT n = 8 and TG n = 17; from four animals). Refer to insets for voltage-step protocols (upper without and lower with inactivation prepulse). (E) Gene expressions of
potassium channel subunits (WT n = 7 and TG n = 6). *P < 0.05, ¤P < 0.01 and #P < 0.001.
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FIGURE 7 | Effect of VEGF-B-related electrophysiological alterations explored
in silico. From top to the bottom: (A,E) [Ca2+]i transients, (B,F) action
potentials, (C,G) currents introduced into model INa, Ito, INCX (solid red lines),
and (D,H) resulting currents IKss, ICaL, IKur (dotted red lines) in simulated
pacing experiments, in the presence (A–D) and absence (E–H) of EGTA. Note,
the different time scale in [Ca2+]i transients panels. The VEGF-B TG model
variant (red lines) accounts for the (1) decreased INa (−18%), (2) reduced Ito
(conductance −49%, and inactivation rate +59%), and (3) increased NCX
current (+36%) as found in experiments.
unaffected QRS represents prolongation of early repolarization
(Liu et al., 2004; Boukens et al., 2013, 2014). That prolongation
fits very good to lengthening of APD60–70 which we observed
in TG cardiomyocytes. That change of QRSp is common
to LVH (Merentie et al., 2015) and some forms of sodium
channelopathies (Remme et al., 2006; Watanabe et al., 2011).
And second is decreased amplitude of the R and S waves,
which has been shown to associate with acute infarction or
ischemia in mouse heart (Gehrmann et al., 2001; Merentie
et al., 2015) and e.g., sodium channel blocker Ajmaline (Boukens
et al., 2013). VEGF-B TG hearts show only modest signs
of organ level hypertrophy and no infarctions, so that the
ECG anomalies cannot be considered as signs of cardiac
disease, but they rather reflect more specific changes in
cardiomyocytes electrophysiology. Interpretation of mouse ECG
is not straightforward (Boukens et al., 2014), but ECG changes
of the VEGF-B mice shown here suggest changes in both
depolarizing and repolarizing currents, which predispose the
heart to arrhythmias upon stress. Cell level electrophysiological
changes such as AP prolongation predispose cardiomyocytes to
afterdepolarization and triggered arrhythmias (Janse, 2004; Aiba
and Tomaselli, 2010). Consequently, APD changes are common
findings in heart diseases, such as heart failure and hypertrophy
(Wickenden et al., 1998), and in a variety genetic mouse models
of human long QT syndrome (Salama and London, 2007).
Due to short APD in mouse ventricular cardiomyocytes, the
depolarizing currents such as L-type Ca2+ current contribute less
to APD than in species with long AP, such as humans. Instead,
mouse AP repolarization is dominated by potassium currents,
especially transient outward currents (Ito,f, Ito,s) (Nerbonne,
2004). VEGF-B TG myocytes have an increase in APD due to
decreased Ito. At the level of K
+ channel transcripts, TGmyocytes
have suppressed expression of Kcnip2. Although translation of
ion channel transcripts to functional channels is subject to
various post-translational modifications and multiple regulative
steps in channels assembly, the protein resulting from Kcnip2
transcript has been shown to be a regulator of Ito (Kuo et al.,
2001) which is in line with our findings and corresponds well
with the previous findings from Kcnip2−/− mice (Thomsen et al.,
2009).
Some of the ECG and action potential findings from VEGF-
B TG hearts cannot be solely explained by the changes in
potassium currents. These include a decrease in the amplitude
of the ECG complex (R and S waves), increased duration of the
QRSp, and the absence of QT lengthening usually associated
with an increase in APD. These changes suggested that the
depolarization phase of the ventricles of VEGF-B mice is also
affected and the ECG changes reflect combinatory effects of both
depolarizing and repolarizing currents of the cardiomyocytes. In
line with this, action potentials of VEGF-B mouse ventricular
myocytes not only had increased duration, but also a decrease
in maximum upstroke velocity as well as an increase in the rise
time of the initial depolarization. The upstroke phase of the AP
is dependent on the Na+-current density and therefore it was
not a surprise that it was accompanied by a reduction in INa
density and a slight rightward shift in the activation-inactivation
curve of the INa in TG cardiomyocytes. Unlike the potassium
channel remodeling, INa changes are not commonly associated
with cardiac hypertrophy or cardiac failure progression (Hill,
2003). Interestingly, according to previous data from mouse
models where the INa downregulation occur as a secondary effect
(Gavillet et al., 2006; Hesse et al., 2007; Cerrone et al., 2012;
Rizzo et al., 2012; Han et al., 2015), or as a result of expression
of mutated Nav1.5 (Remme et al., 2006; Abriel, 2007; Watanabe
et al., 2011), the electrophysiological findings in mouse heart are
similar to those in VEGF-B TGmice. Prototypically these include
decreases in the QRS complex amplitude, reduced upstroke
velocity of the AP, and reduced conduction velocity. Therefore,
it appears that the electrophysiological phenotype of the VEGF-
B TG hearts is greatly impacted by the downregulation of the
Na+-current. According to the simulations with a mathematical
model, the measured changes in Ito and INa densities together
with the changes in their activation/inactivation properties
explain well the measured changes in the AP shape. Interestingly,
the modeling also suggests that the modest changes in calcium
transient amplitude at low pacing frequencies actually results
from the AP lengthening. That is, slower initial AP repolarization
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decelerate the inactivation of the ICaL and consequently increases
to total Ca2+ influx via ICaL during AP in VEGF-B TG myocytes.
The effects of VEGF-B on the structure and function of the
heart have been studied with a wide variety of animal models
and approaches (Bry et al., 2014). It has become evident that
some of the VEGF-B effects show species or isoform specificity,
whereas others depend on methods used for overexpression
or knockdown. The TG mice analyzed in this study showed a
relatively mild tendency to hypertrophy, indicating that the effect
of VEGF-B on cardiac phenotype is graded, producing milder
changes with less powerful transgene expression. Collectively
the existing data show that VEGF-B induces a spectrum of
changes in the heart ranging from capillary density and structure
and growth of the myocardium to more diffuse changes in
energy substrate metabolism and signaling. Bearing this in mind
it is a surprise that the cardiomyocyte-level phenotype of the
VEGF-B TG mice show minimal alterations in Ca2+ signaling,
contraction, or structure. Instead, TG hearts have a very distinct
and specific electrophysiological phenotype originating from
precise changes in ion current densities. This suggests that VEGF-
B triggers pathways mediating cardiomyocyte-specific alterations
in electrophysiology without directly affecting the contractile
function of the whole heart.
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